Cargando…

Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney Transplantation

Within this prospective, open-label, self-controlled study, we evaluated the long-term effects of the calcimimetic cinacalcet on calcium and phosphate homeostasis in 44 kidney transplant recipients (KTRs) with hypercalcemic hyperparathyroidism by comparing biochemical parameters of mineral metabolis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiem, Ursula, Gessl, Alois, Borchhardt, Kyra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377458/ https://www.ncbi.nlm.nih.gov/pubmed/25861621 http://dx.doi.org/10.1155/2015/292654

Ejemplares similares

Therapy for persistent hypercalcemic hyperparathyroidism post-renal transplant: cinacalcet versus parathyroidectomy
por: Rivelli, Gabriel Giollo, et al.
Publicado: (2020)

Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation
por: Mawad, Habib, et al.
Publicado: (2017)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?
por: Amaral, L. M., et al.
Publicado: (2012)

VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients: A randomized, placebo-controlled study to evaluate the post-transplant outcome
por: Thiem, Ursula, et al.
Publicado: (2009)

Calcidiol Deficiency in End-Stage Organ Failure and after Solid Organ Transplantation: Status quo
por: Thiem, Ursula, et al.
Publicado: (2013)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Otsuka, Keiichi, et al.
Publicado: (2018)

Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
por: Behets, Geert J, et al.
Publicado: (2015)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
por: Susantitaphong, Paweena, et al.
Publicado: (2019)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2019)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients
por: Koiwa, Fumihiko, et al.
Publicado: (2021)

Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study
por: Forni Ogna, Valentina, et al.
Publicado: (2013)

Effects of Cinacalcet on Post-transplantation Hypercalcemia and Hyperparathyroidism in Adult Kidney Transplant Patients: A Single-Center Experience
por: Alpay, Nadir, et al.
Publicado: (2023)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
por: Patel, Rima, et al.
Publicado: (2020)

Primary hyperparathyroidism presenting as hypercalcemic crisis: Twenty-year experience
por: Singh, Dependra Narayan, et al.
Publicado: (2015)

Heart Block and Acute Kidney Injury Due to Hyperparathyroidism-Induced Hypercalcemic Crisis
por: Brown, Taylor C., et al.
Publicado: (2014)

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study
por: Jung, Suyun, et al.
Publicado: (2022)

A case of primary hyperparathyroidism with hypercalcemic nephropathy in children.
por: Yu, J. M., et al.
Publicado: (1994)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
por: Elhadedy, Muhammed Ahmed, et al.
Publicado: (2023)

Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
por: Meola, Mario, et al.
Publicado: (2009)

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
por: Nakayama, Kazunori, et al.
Publicado: (2013)

Sarcoidosis and primary hyperparathyroidism simultaneously occurring in a hypercalcemic patient
por: Hassan, Syed, et al.
Publicado: (2012)

Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism
por: Viviani, Arianna, et al.
Publicado: (2023)

Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism
por: Ni, Zhaohui, et al.
Publicado: (2023)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
por: Nguyen, Son, et al.
Publicado: (2020)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
por: Jeong, Sohyun, et al.
Publicado: (2016)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
por: Ng, Cheng Han, et al.
Publicado: (2020)

Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism
por: Timmons, J. G., et al.
Publicado: (2021)

Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
por: Thakkar, Keya, et al.
Publicado: (2021)

Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism
por: Beysel, Selvihan, et al.
Publicado: (2019)

Primary hyperparathyroidism presenting as acute hypercalcemic crisis: a case report
por: Gill, Gia, et al.
Publicado: (2023)

Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis
por: Xu, Wei, et al.
Publicado: (2020)

Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience
por: Mogl, M. T., et al.
Publicado: (2020)

The effects of discontinuing cinacalcet at the time of kidney transplantation
por: Jadoul, Michel, et al.
Publicado: (2010)

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl
por: Eriguchi, Rieko, et al.
Publicado: (2008)

Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients
por: Fisher, Marisa M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rkgb4ruu3bupphl0ckein8puvs